Weekly Psychedelic Links

This Week in Psychedelics - 10.22.21

Cannabis

  • Luxembourg first in Europe to legalise growing and using cannabis (The Guardian)

  • Switzerland to legalise recreational and medical cannabis usage (The Local)

  • Virginia Has Sealed 64,000 Marijuana Distribution Charges Since Legalization Took Effect This Summer (Marijuana Moment)

  • New York: Employers Are Prohibited from Testing Most Employees for Cannabis (NORML)

  • Top Mexican Senator Says Marijuana Legalization Bill May Be Taken Up Within Weeks (Marijuana Moment)

  • South Dakota Lawmakers Advance Marijuana Legalization Bill As Activists Pursue 2022 Ballot Initiative (Marijuana Moment)

  • Oregon illegal pot grows: More calls to send National Guard (AP News)

  • USPS Releases Final Rule Banning Mailing Of Hemp, CBD And Marijuana Vapes (Marijuana Moment)

  • Alabama Announces Medical Cannabis Licenses Won’t Be Available Until 2022 (High Times)

  • Impact Of Marijuana Legalization On Crime Reduction Is Being Underestimated, New Study Finds (Marijuana Moment)

  • Recreational Cannabis Law in Washington, D.C. May Soon Be Operational (High Times)

  • New York: Officials Advance Home Cultivation Regulations for Qualified Patients (NORML)

  • Minnesota Denies Coverage of Medical Marijuana for Injured Workers (High Times)

  • Brit jailed for 25 years in Dubai over CBD vape oil speaks of 'shocking' conditions in call to mum (ITV)

  • Indica and Sativa Labels Can’t Be Trusted, Study Indicates (High Times)

  • Americans Want To Live Where Marijuana Is Legal, Real Estate Survey Finds (Marijuana Moment)

  • Study: Cannabis Use Benefits ADHD Symptoms in Adults, According to Self-Reports (ADDitude)

LSD

  • LSD vs. Psilocybin Microdosing for Mental Health and Workplace productivity (The Third Wave)

  • Can You Overdose On LSD? This Is What To Know (Healing Maps)

Magic Mushrooms

  • Boris Johnson to consider calls to legalise magic mushroom drug psilocybin (BBC)

  • Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups (Psilocybin Alpha)

  • COMPASS Pathways is granted new US patent for crystalline psilocybin (Psilocybin Alpha)

  • Doing Shrooms Alone: The Art of Tripping Solo (DoubleBlind)

  • Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and Health Benefit of Amanita Muscaria Mushroom (AME-1) To Inhibit Human Mast Cell Activation (Psilocybin Alpha)

  • The “Unsung History” of Psilocybin Research: Gastón Guzmán and His Scientific Contribution (Chacruna)

  • Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

  • Magic Mushrooms Could One Day Treat Depression. How Do They Work? (ScienceAlert)

MDMA

DMT

  • First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial (Psilocybin Alpha)

  • Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Novel Psychoactive Substances

  • Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies (Psilocybin Alpha)

  • Emyria passes MDMA analogue development milestone with Eurofins to lead extensive compound screening program (Proactive Investors)

Nitrous Oxide

  • Nang gang: Nitrous oxide helps alleviate depression, study finds (The Big Smoke)

Ketamine

  • Are Ketamine Clinics Paving the Way for Legal Psychedelic Therapy? (DoubleBlind)

  • Why Ketamine-Assisted Therapy Has Gone Mainstream (Forbes)

  • PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products (Psilocybin Alpha)

Miscellaneous

  • Easthampton, Mass. Decriminalizes Natural Psychedelics (DoubleBlind)

  • Oakland Psychedelics Activists Launch Initiative To Legalize Community-Based Sales With Support From City Council (Marijuana Moment)

  • DEA Proposes Dramatic Increase In Marijuana And Psychedelic Production In 2022, Calling For 6,300 Percent More MDMA Alone (Marijuana Moment)

  • Preventing Sexual Abuse in Psychedelic Therapy (Psychedelic Spotlight)

  • Bank Of America Cancels Account Of Marijuana And Psychedelics Research Institute Registered With DEA (Marijuana Moment)

  • Activist Apes Erect 2,001-Pound Monolith In Front Of DEA Headquarters, Demanding Feds ‘Evolve’ On Drug Policy (Marijuana Moment)

  • How Do I Talk To My Doctor About Psychedelics? (Truffle Report)

  • Addressing Abuse and Repair: An Open Letter to the Psychedelic Community (Chacruna)

  • This New Company Believes Psychedelics Can Treat Dementia (Psychedelic Spotlight)

  • Campaign Launches to Decriminalize Drugs in Washington, DC (Filter)

  • Can microdosing psychedelics impact an insurance application? (News24)

  • Even in a Year of Massive Reforms, Racist Myths Pervade the Drug Policy Debate (TalkingDrugs)

  • Countdown to ecstasy: how music is being used in healing psychedelic trips (The Guardian)

  • Homecoming: The Psychedelic Digital Companion Therapists Are Already Using (Forbes)

  • The Whitewashing of Psychedelic Medicine (Reality Sandwich)

  • Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton (Psilocybin Alpha)

  • Baltimore Study Boosts Movements to Decriminalize Drugs and Sex Work (Filter)

  • Carlos Santana still takes hallucinogens (MSN)

  • ‘Shrooms! Shamans! Kosher LSD! Why Los Angeles Is Suddenly Tripping Out (Los Angeles Magazine)

  • How Nutrition Can Improve the Psychedelic Experience (Psychedelic Spotlight)

  • Why creatives should microdose LSD and cannabis before big pitches (AdAge)

  • Psychedelics and Sports: Can They Propel Athletes to Unprecedented Pinnacles of Ability? (Psychedelic Spotlight)

  • Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders (Psilocybin Alpha)

  • The Neuroanatomy of a Psychedelic Trip: The Basics (Healing Maps)

  • atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness the Power of Innovative Mental Health Approaches for Positive Social Change (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.15.21

Cannabis

  • Man to be Hanged in Singapore for Importing About Two Pounds of Pot (High Times)

  • Activists seek to legalise marijuana in hippie haven of Nepal (The Times)

  • Companies are selling saliva kits so customers can figure out the best marijuana strain and get HIGH (Today UK News)

  • Republican Ohio Lawmakers Announce Marijuana Legalization Bill, Reflecting Recent Bipartisan Shift On Issue (Marijuana Moment)

  • New NORML Report Highlights Concerns Regarding Sale of Unregulated Delta-8 THC, Similar Products (NORML)

  • Marijuana legalization used to right wrongs from drug war (UPI)

  • Virginia Medical Marijuana Patients See High Prices And Long Waits For Approvals (Marijuana Moment)

  • Harborside Announces Planned Commercial-Scale Renewable Energy Microgrid Project at Salinas Production Campus (PR Newswire)

  • South Dakota Activists Launch Marijuana Legalization Signature Drive To Get On 2022 Ballot (Marijuana Moment)

  • Survey: 60% of cannabis users want to get high with a grandparent (Leafly)

  • Mississippi ‘Not Quite Ready’ to Implement Medical Cannabis (High Times)

LSD

  • Is LSD Addictive? Is It Safe To Use For Mental Health Issues? We Provide Guidance (Healing Maps)

Magic Mushrooms

San Pedro

  • What is San Pedro? Facts about the Psychoactive Plant (The Third Wave)

Ketamine

Miscellaneous

  • Voters Across The U.S. Will Decide On Marijuana And Psychedelics Ballot Measures Next Month (Marijuana Moment)

  • How COVID-19 Opened the Door to a New Era in Psychedelic Medicine (TIME)

  • No, Psychedelic Treatment Doesn't Look Like 'Nine Perfect Strangers' (Verywell Health)

  • On Sacred Reciprocity: Giving Back to our Indigenous Predecessors in the Psychedelic Movement (Psychedelic Spotlight)

  • Trying Psychedelics Just Once Might Reduce Your Chances Of Cardiometabolic Disease, Study Finds (IFLScience)

  • Is Mysticism Becoming A Problem For Psychedelic Medicine? (Forbes)

  • Is There a Dependable Way to Induce an Ego Death Experience with Psychedelics? (Lucid News)

  • Ego Death: Is This The Most Important Result From Psychedelic Therapy? (Healing Maps)

  • Why Psychedelic Stocks Have Crashed in the Last 3 Months (Psychedelic Spotlight)

  • Navigating a Double-Edged Sword: Toward Psychedelic Apprenticeship (Chacruna)

  • Psychedelic Reciprocity: Patents and Indigenous Knowledge (Truffle Report)

  • Stewarding Psychedelic and Ecological Biospheric Wisdom with Deborah Parrish Snyder (Chacruna)

  • Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities (Psilocybin Alpha)

  • The Therapeutic Effects of Psychedelics: 2A or Not 2A?-Part 2 (Psychedelic Science Review)

  • Exploring Creepy Psychedelic Art (Reality Sandwich)

  • Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the COPE Program with InterVivo Solutions (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.8.21

ThisWeekinPsychedelics.png

Cannabis

  • Philadelphia Will Vote On Marijuana Referendum Calling For Statewide Legalization Next Month (Marijuana Moment)

  • Top Mexican Senator Lays Out Next Steps For National Marijuana Legalization (Marijuana Moment)

  • Nevada: New Marijuana Laws Took Effect This Month (NORML)

  • Portugal Delays Recreational Cannabis Bills as Luxembourg Also Signals Delay (High Times)

  • New York: Regulators Approve Patients’ Access to Medical Cannabis Flower (NORML)

  • NBA Won’t Randomly Drug Test Players For Marijuana For Another Season, League Announces (Marijuana Moment)

  • Lung Injuries Tied To Contaminated Vapes Were Less Common In States With Legal Marijuana And Homegrow, Study Finds (Marijuana Moment)

  • California Legalizes Smokable Hemp and Food Sales in Historic Bill (High Times)

  • Preconception cannabis use linked to an increased risk of postpartum depression (PsyPost)

  • More Than A Dozen Ohio Cities Will Vote On Marijuana Decriminalization Ballot Measures Next Month (Marijuana Moment)

  • CBGA More Effective For Seizures Than CBD, Study of Mice Finds (High Times)

  • Study: Cannabis Use Disorder Diagnosis Associated with Greater Risk of COVID Breakthrough Infections — NORML Responds (NORML)

  • Bipartisan Pennsylvania Senators Unveil Marijuana Legalization Bill Amid Whirlwind Of Reform Efforts In The State (Marijuana Moment)

  • Oklahoma Activists File Marijuana Legalization And Medical Cannabis Reform Initiatives For 2022 Ballot (Marijuana Moment)

LSD

Magic Mushrooms

  • GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders (Marijuana Moment)

  • Denver may ease magic mushrooms laws further two years after decriminalization (The Denver Post)

  • Is Denver’s Psilocybin Decriminalization Having an Impact? (Filter)

  • Psychedelic drug changes the emotional state of people listening to music (News-Medical.net)

  • "Homebrew" Psilocybin Created By Scientists Using "Widely Available" Materials (IFLScience)

  • Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson (Mydecine)

  • Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio (Psilocybin Alpha)

  • Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1 (Psilocybin Alpha)

MDMA

  • Why You Vom When You’re Coming Up On MDMA (VICE)

  • MDMA-assisted psychotherapy associated with sleep improvements among PTSD patients (PsyPost)

Peyote

  • Santa Cruz Removes Peyote And Other Mescaline-Containing Cacti From Psychedelics Decriminalization Law (Marijuana Moment)

Novel Psychoactive Substances

Ketamine

  • Recreational ketamine use has increased in recent years, but remains rare (Medical Xpress)

  • PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease (Psilocybin Alpha)

Miscellaneous

  • Seattle Becomes Largest U.S. City To Decriminalize Psychedelics (Marijuana Moment)

  • Arcata, California Decriminalizes Psychedelics (Truffle Report)

  • The Psychedelics Industry Could Offer a Whole New Approach to Work (Rolling Stone)

  • Will Smith Recalls Life-Changing Psychedelic Experiences in New Book (High Times)

  • PSYCH Publishes Third Edition of The Psychedelics as Medicine Report (PR Newswire)

  • Toronto’s Bid to Decriminalize Drugs Hangs in the Balance (Filter)

  • The Need for New Psychedelic Compounds (Psychology Today)

  • Risks of Serotonin Syndrome when Combining Psychedelics with Antidepressants (Chacruna)

  • The 'Psychedelic Renaissance' Is Entirely About Corporate Greed (Caitlin Johnstone)

  • Becoming a Yes-Sayer: Psychedelics, Nietzsche, and the Affirmation of Life (Sam Woolfe)

  • Will Psychedelic Companies Embrace Indigenous Reciprocity? (Lucid News)

  • What Is Hallucinogen-Persisting Perception Disorder (HPPD)? (PsychCentral)

  • Anima Mundi: Psychedelics and The Ensouled Earth (Psychedelics Today)

  • Ensuring Equity in Psychedelic Science and Businesses (Truffle Report)

  • Death and psychedelics: How science is reviving this ancient connection (Leafly)

  • DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t (Psymposia)

  • Psychedelic-Induced Psychological Flexibility Can Reduce Racial Trauma (Truffle Report)

  • Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison (Psilocybin Alpha)

  • Psychedelics and Mental Health Therapy in Colorado: DORA and Potential Regulatory Response (JD Supra)

  • Psychedelics and Perception Part 2: The First Era of Research (Psychedelic Science Review)

  • It’s one big mistake (New Amsterdam Psychedelic Law)

  • Madison Margolin Sounds Off on Mainstreaming of Cannabis and Psychedelics Cultures (CelebStoner)

  • Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities (PR Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.1.21

ThisWeekinPsychedelics.png

Cannabis

  • Bill To Federally Legalize Marijuana Approved By Key House Committee (Marijuana Moment)

  • Marijuana Arrests Fall Precipitously Nationwide in 2020 (NORML)

  • California Governor Signs Bill To Allow Medical Marijuana Use In Hospitals For Severely Ill Patients (Marijuana Moment)

  • Kansas City, MO: City Council Approves Measure Eliminating Pre-Employment Marijuana Testing for Most City Workers (NORML)

  • Hundreds prescribed medical cannabis in bid to persuade lawmakers to offer it on NHS (Mirror)

  • Mississippi Lawmakers Move to Implement Medical Cannabis Legislation (High Times)

  • Los Angeles: District Attorney to Vacate Some 60,000 Marijuana Convictions (NORML)

  • DEA Still Insists Marijuana Has No 'Accepted Medical Use' (Reason)

  • The Making Of New York’s $150 Million ‘Cannabis Campus’ (Forbes)

  • What are they smoking? CNN says study found cannabis could double heart attack risk – but did it? (The Cannigma)

  • Pennsylvania Lawmakers Unveil Marijuana Legalization Bill With Focus On Social Equity (Marijuana Moment)

  • Your Smartphone Can Tell If You’re High On Marijuana, Study Finds (Forbes)

  • Nebraska Advocates Launch Signature Drive For 2022 Medical Marijuana Ballot Measures (Marijuana Moment)

  • Curbside Recreational Weed Pickups End in Massachusetts (High Times)

  • Federal Grant Approved to Study Medical Marijuana Impact in Arkansas (High Times)

LSD

  • Cannot treat LSD and its carrier material as separate, says court Cannot treat LSD and its carrier material as separate, says court (The Times of India)

Magic Mushrooms

  • From Sugar To Psychedelics: The European Companies Testing Biosynthetic Psilocybin In Humans (Forbes)

  • Decrim California’s Plan to Regulate Psilocybin Via Ballot (Truffle Report)

  • My Bipolar Mother's Quest For Relief With Magic Mushrooms (VICE)

  • Oregon Board to Vote on Psilocybin Facilitator Program (Truffle Report)

  • Red Light Holland: Initial Results From Red Light Oregon Market Research in Oregon Show 86% of Adults Interested in Psilocybin Services are Interested in Microdosing (Psilocybin Alpha)

MDMA

  • MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy (Psilocybin Alpha)

  • Levels of MDMA and cocaine in river running through Glastonbury Festival site so high they could harm wildlife, scientists say (Independent.ie)

  • Police urging parents to inspect Halloween candy after ecstasy discovered (Fox News)

  • MDMA: A Catalyst for ED-PTSD Treatment (Psychedelic Science Review)

DMT

  • Companies Compete to Create DMT Therapies (Lucid News)

Ayahuasca

  • Will Smith Embarked On A Dozen Ayahuasca Rituals In Peru After Denzel Washington Sold Him On The “F*ck It 50s” (BroBible)

  • Man charged after alleged sex assault linked to ayahuasca ceremony (CBC)

Novel Psychoactive Substances

  • Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders (Psilocybin Alpha)

  • BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders (Psilocybin Alpha)

  • Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates (Psilocybin Alpha)

Ketamine

  • Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate (News-Medical.net)

Miscellaneous

  • Ending The Silence Around Psychedelic Therapy Abuse (Mad in America)

  • Can Psychedelic Drugs Treat Physical Pain? (Scientific American)

  • Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre (Psilocybin Alpha)

  • Seattle City Council Takes First Step Toward Decriminalizing Psychedelic Plants And Fungi (Marijuana Moment)

  • Florida Lawmakers Introduce Bill to Study Psychedelics (Truffle Report)

  • DoubleBlind Magazine's First-Ever Psychedelics Billboard Campaign Is Turning New Yorkers On To Plant Medicine (Benzinga)

  • Psychedelics might reduce internalized shame and complex trauma symptoms in those with a history of childhood abuse (PsyPost)

  • Massachusetts Lawmakers Discuss Drug Decriminalization And Safe Injection Sites At Hearing (Marijuana Moment)

  • Bay Staters for Natural Medicine on Easthampton Decrim (Truffle Report)

  • ‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health (The Guardian)

  • Are Psychedelic Drugs the Answer to Veterans’ PTSD? (Men's Health)

  • 19-Year-Old New Hampshire Lawmaker Prepares Bills To Decriminalize Psilocybin And All Drugs (Marijuana Moment)

  • Elon Musk Embraces Potential of Psychedelics at CodeCon (High Times)

  • How Effective Is Fireside Project's Psychedelic Hotline? New Study Aims To Find Out (Forbes)

  • Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality (Psychedelics Today)

  • Pantheistic Insights: Vegetarianism in Psychedelic Culture (The Oak Tree Review)

  • 'The End In Mind' Conference Answers Questions About Psychedelics For End-Of-Life Patients (Forbes)

  • Community Alert! Arrests and Encounters with Law Enforcement are Increasing (Chacruna)

  • People Are Facing Legal Repercussions for Serving Plant Medicine — Here’s What’s Being Done to Help Them (DoubleBlind)

  • Does psychedelic microdosing work? Brain study will be the real acid test (The New Daily)

  • Psychedelia in the Soviet Union (Reality Sandwich)

  • The Mystical Experience Defines Psychedelics (Lucid News)

  • Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases (PR Newswire)

  • Why Psychedelic Therapy Needs Best Practices & How to Get There (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.